Workflow
ASR(688220)
icon
Search documents
【机构调研记录】银华基金调研翱捷科技、北方稀土等4只个股(附名单)
Zheng Quan Zhi Xing· 2025-08-04 00:08
Group 1: Aojie Technology - Aojie Technology has made significant progress in ASIC business, RedCap chips, and 4G/5G smartphone chips [1] - The ASIC business is focused on smart wearables, edge SOC, RISC-V, and cloud inference chips, with expected substantial revenue growth by 2026 [1] - RedCap chips are commercially available in the IoT market, and the company has production capabilities for smart wearables [1] - The company has successfully commercialized 4G quad-core chips and is making steady progress in the development of 4G octa-core, 6nm 4G octa-core, and 6nm 5G octa-core chips [1] - The company plans to control the growth of period expenses and R&D expenses to no more than 15% [1] Group 2: Northern Rare Earth - The research focused on the integration prospects of the domestic rare earth industry, total control indicators, downstream demand expectations, and the heavy rare earth reserves in the Baiyun Obo mine [2] - The company believes that the domestic rare earth industry is accelerating integration under policy drivers, forming a "one south, one north" pattern to enhance international competitiveness [2] - The total control indicators for this year consider market, production, and supply-demand situations, aligning with new policy requirements [2] - Future downstream demand for rare earths is expected to grow due to green low-carbon initiatives and emerging fields [2] - The Baiyun Obo mine has heavy rare earth reserves of several hundred thousand tons [2] - The company plans to continue increasing its dividend rate to enhance stability and provide better returns to shareholders [2] Group 3: Jianlong Micro-Nano - Jianlong Micro-Nano is progressing with a major asset restructuring to acquire Shanghai Hanxing Energy Technology Co., Ltd. to expand high value-added projects [3] - The second phase of the Thailand Jianlong project has been put into production, with an annual capacity of 24,000 tons, targeting overseas markets [3] - Future growth points are expected from market expansion in traditional and new product areas, including industrial gas separation and adsorption drying [3] - The company will not adjust the conversion price during a specific period [3] Group 4: Xingye Silver Tin - The research covered the progress of Yinman Phase II, Yubang Mining expansion, and the company's development strategy [4] - Yinman Phase II has received project approval and is in communication with the government for construction permits [4] - Yubang Mining's 8.25 million ton expansion project is applying for construction permits [4] - The company focuses on silver and tin as core businesses while gradually integrating copper and gold resources [4] - The Yubang Mining expansion project is expected to produce 450 tons of silver annually upon reaching full capacity [4] - The company has established a comprehensive safety management system and emphasizes investment in safety [4] - The company has good exploration prospects for its Moroccan project [4]
【机构调研记录】长信基金调研翱捷科技、皓元医药等3只个股(附名单)
Zheng Quan Zhi Xing· 2025-08-04 00:08
Group 1: Aojie Technology - Aojie Technology has made significant progress in ASIC business, RedCap chips, and 4G/5G smartphone chips [1] - The ASIC business is focused on smart wearables, edge SOC, RISC-V, and cloud inference chips, with expected substantial revenue growth by 2026 [1] - RedCap chips are commercially available in the IoT market, and the company has production capabilities in the smart wearable market [1] - The company has successfully commercialized 4G quad-core chips and is making steady progress in the development of 4G octa-core, 6nm 4G octa-core, and 6nm 5G octa-core chips [1] - Aojie Technology plans to control the growth of operating and R&D expenses to no more than 15% and has no plans for convertible bond issuance or Hong Kong listing [1] Group 2: Haoyuan Pharmaceutical - Haoyuan Pharmaceutical is committed to a global development strategy, with international business revenue expected to account for nearly 40% in 2024 [1] - The company has established collaborations with multinational pharmaceutical giants, universities, research institutes, and CROs [1] - The net operating cash flow is projected to turn positive to 380 million yuan in 2024, with continued focus on cash flow management in 2025 [1] - The company has a strong presence in the ADC field, with the Chongqing ADC CDMO factory providing one-stop services [1] - Haoyuan Pharmaceutical emphasizes ESG practices, having established an ESG governance framework and received multiple ESG awards [1] Group 3: Chongda Technology - Chongda Technology anticipates positive growth in the global PCB market by 2025, with strong order demand and rising product prices [2] - The company's capacity utilization rate is at 85%, with new production capacities being added in Zhuhai and Thailand [2] - To improve profitability, Chongda Technology is focusing on high-value customers, optimizing sales structure, and enhancing cost management [2] - The company is implementing a structural price increase strategy to address rising raw material costs [2] - The U.S. market accounts for 10% of the company's revenue, and it is adopting strategies to diversify markets and optimize customer cooperation in response to tariff policy changes [2]
电子行业一周净流出资金204.37亿元,66股净流出资金超亿元
Market Overview - The Shanghai Composite Index fell by 0.94% this week, with six industries experiencing gains, led by the pharmaceutical and communication sectors, which rose by 2.95% and 2.54% respectively [1] - The electronic industry also saw a slight increase of 0.28% [1] Fund Flow Analysis - A total of 211.86 billion yuan was net withdrawn from the two markets this week, with only the banking sector seeing a net inflow of 4.33 billion yuan [2] - The non-ferrous metals industry had the largest net outflow, totaling 25.99 billion yuan, followed by the computer industry with a net outflow of 20.45 billion yuan [2] Industry Performance - The banking sector experienced a decline of 0.84% with a net inflow of 4.33 billion yuan, while the real estate sector fell by 3.43% with a net outflow of 4.38 billion yuan [3] - The pharmaceutical and communication sectors were the only industries to post gains, while the coal and non-ferrous metals sectors saw declines of 4.67% and 4.62% respectively [3] Electronic Industry Insights - Within the electronic industry, 465 stocks were tracked, with 198 stocks rising and 266 stocks falling this week [3] - Notable gainers included Dongxin Co., which rose by 53.68%, and Sifang New Materials, which increased by 50.75% [3] - Major losers included Wavelength Optoelectronics, which fell by 10.06%, and Fengcai Technology, which dropped by 8.50% [3] Individual Stock Performance - In the electronic sector, 112 stocks saw net inflows, with 23 stocks receiving over 100 million yuan in net inflows, led by Industrial Fulian with 5.12 billion yuan [4] - Conversely, 66 stocks experienced net outflows exceeding 100 million yuan, with the largest outflow from SMIC at 1.26 billion yuan [4][6] ETF Performance - The Consumption Electronics ETF (code: 159732) tracked the National Certificate Consumption Electronics Theme Index, showing a slight increase of 0.46% over the past five days [8] - The ETF's latest share count was 2.47 billion, a decrease of 23 million shares, with a net inflow of 19.01 million yuan [8]
翱捷科技U(688220)7月31日主力资金净流入8492.37万元
Sou Hu Cai Jing· 2025-07-31 07:38
金融界消息 截至2025年7月31日收盘,翱捷科技U(688220)报收于88.32元,下跌0.01%,换手率 3.61%,成交量13.01万手,成交金额11.66亿元。 资金流向方面,今日主力资金净流入8492.37万元,占比成交额7.28%。其中,超大单净流入2172.62万 元、占成交额1.86%,大单净流入6319.75万元、占成交额5.42%,中单净流出流入143.74万元、占成交 额0.12%,小单净流出8636.11万元、占成交额7.41%。 天眼查商业履历信息显示,翱捷科技股份有限公司,成立于2015年,位于上海市,是一家以从事软件和 信息技术服务业为主的企业。企业注册资本41830.0889万人民币,实缴资本22932.64万人民币。公司法 定代表人为戴保家。 通过天眼查大数据分析,翱捷科技股份有限公司共对外投资了12家企业,参与招投标项目28次,知识产 权方面有商标信息37条,专利信息261条,此外企业还拥有行政许可37个。 来源:金融界 翱捷科技最新一期业绩显示,截至2025一季报,公司营业总收入9.10亿元、同比增长9.61%,归属净利 润12223.83万元,同比增长2.43%,扣非 ...
翱捷科技: 关于参与投资私募基金暨关联交易的公告
Zheng Quan Zhi Xing· 2025-07-29 16:43
Core Viewpoint - The company plans to invest RMB 40 million as a limited partner in the Shanghai Haiwang Hezhong Private Equity Fund, which focuses on industries related to integrated circuits, high-end manufacturing, and biomedicine, aligning with the company's main business [1][3][19]. Investment Overview - The investment will constitute approximately 1.8957% of the total subscribed capital of the fund, which is set at RMB 2.11 billion [1][7]. - The investment aims to leverage the expertise and resources of professional investment institutions to optimize the company's investment structure and capture industry opportunities [3][17]. Related Party Transactions - The limited partner Shanghai Pudong Science and Technology Innovation Group, a shareholder of the company, holds 604,731 shares, representing 0.14% of the company [2][4]. - The transaction is classified as a related party transaction but does not constitute a major asset restructuring as per regulations [2][5][19]. Approval Process - The transaction has been approved by the company's board of directors and independent directors, with the related party abstaining from voting [2][19]. - The approval process complies with relevant regulations and does not require shareholder meeting approval [19][20]. Fund Management and Structure - The fund will have a management fee of 2% per year based on the subscribed capital during the investment period [11][12]. - The fund's investment period is set for five years, with a total duration of eight years unless extended [9][14]. Financial Impact - The investment will not be consolidated into the company's financial statements and will not impose financial pressure on the company's existing operations [17][19]. - The investment is expected to enhance the company's market competitiveness and investment strategies without adversely affecting shareholder interests [19][20].
翱捷科技(688220.SH)拟4000万元参投海望合纵 布局集成电路、高端制造等多个领域
智通财经网· 2025-07-29 14:00
Group 1 - The company plans to invest 40 million yuan as a limited partner in the Shanghai Haiwang Hezhong Private Equity Fund, accounting for 1.8957% of the total committed capital of the fund [1] - The Haiwang Hezhong fund will primarily invest in growth and mature companies in key industries such as integrated circuits, high-end manufacturing, and biomedicine, among others [1] - The investment aims to leverage the expertise and resources of professional investment institutions to broaden investment methods and channels, optimize the company's investment structure, and seize industry investment opportunities [1]
翱捷科技拟4000万元参投海望合纵 布局集成电路、高端制造等多个领域
Zhi Tong Cai Jing· 2025-07-29 13:59
Core Viewpoint - The company, Aojie Technology (688220.SH), plans to invest 40 million yuan as a limited partner in the Shanghai Haiwang Hezhong Private Equity Fund, representing 1.8957% of the total committed capital of the fund [1] Investment Details - The investment will focus on growth and mature enterprises in key sectors such as integrated circuits, high-end manufacturing, biomedicine, and other "3+6" priority industries [1] - The investment aims to leverage the expertise and resources of professional investment institutions to broaden investment methods and channels [1] Strategic Objectives - The company seeks to optimize its investment structure and seize investment opportunities within its industry [1] - The investment is intended to achieve industrial synergy by capitalizing on the opportunities presented in the industry [1]
翱捷科技(688220.SH):拟4000万元出资参与投资私募基金
Ge Long Hui A P P· 2025-07-29 13:48
Core Viewpoint - The company, Aojie Technology (688220.SH), aims to leverage the expertise and resources of professional investment institutions to enhance its investment strategies and seize opportunities within its industry [1] Investment Strategy - The company plans to participate as a limited partner (LP) in the investment of Haiwang Hezhong, which will focus on investing in growth and mature enterprises in key sectors such as integrated circuits, high-end manufacturing, biomedicine, and other "3+6" priority industries [1] - The company intends to invest RMB 40 million, representing 1.8957% of the total committed capital of the fund, with the final details to be confirmed in the partnership agreement [1] Risk Management - In this investment, the company has not committed to providing guaranteed returns or exit guarantees to other investors [1]
翱捷科技(688220) - 国泰海通证券股份有限公司关于翱捷科技股份有限公司参与投资私募基金暨关联交易的核查意见
2025-07-29 13:33
国泰海通证券股份有限公司 关于翱捷科技股份有限公司 参与投资私募基金暨关联交易的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐机构")作 为翱捷科技股份有限公司(以下简称"翱捷科技"或"公司")首次公开发行 股票并上市持续督导的保荐机构,根据《证券发行上市保荐业务管理办法》 《上海证券交易所科创板股票上市规则》《上海证券交易所上市公司自律监管 指引第 11 号——持续督导》《上海证券交易所科创板上市公司自律监管指引第 1号——规范运作》等相关法律、法规和规范性文件的规定,对翱捷科技参与投 资私募基金暨关联交易的事项进行了核查,核查情况与意见如下: 一、参与投资私募基金暨关联交易概述 (一)关联交易基本情况 海望合纵的有限合伙人上海浦东科创集团有限公司(以下简称"浦东科 创")属于公司股东,持有公司股份604,731股,持股比例为0.14%。浦东科创 与另外两名公司股东上海浦东新星纽士达创业投资有限公司、上海浦东新兴产 业投资有限公司为一致行动人,共持有公司股份31,833,531股,合计持股比例为 1 7.61%。 为借助专业投资机构的经验和资源,拓宽投资方式和渠道,把握公司所在 行业的投资 ...
翱捷科技(688220) - 关于参与投资私募基金暨关联交易的公告
2025-07-29 13:30
证券代码:688220 证券简称:翱捷科技 公告编号:2025-031 翱捷科技股份有限公司 关于参与投资私募基金暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 投资基金名称及投资方向,与公司主营业务相关性:上海海望合纵私募 基金合伙企业(有限合伙)(以下简称"海望合纵"),海望合纵将主要通过 直接或间接方式投资于包括集成电路、高端制造、生物医药以及其他"3+6"重 点产业等领域的成长期、成熟期的企业,与公司主营业务具有相关性。 投资金额、在投资基金中的占比及身份:翱捷科技股份有限公司(以下 简称"公司")拟作为有限合伙人(LP)以自有资金出资人民币4,000万元,参 与投资海望合纵,占海望合纵总认缴出资金额比例约1.8957%(具体情况以最终 签署的《合伙协议》为准)。 关联交易情况:海望合纵的有限合伙人上海浦东科创集团有限公司(以 下简称"浦东科创")属于公司股东,持有公司股份604,731股,持股比例为 0.14%。浦东科创与另外两名公司股东上海浦东新星纽士达创业投资有限公司、 上海 ...